Refardt J, Imber C, Nobbenhuis R, Sailer CO, et al. Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. J Am Soc Nephrol 2023;34:322-332.
PMID: 36396331